The use of glibenclamide to control plasma glucose after TBI had no significant effect on patient outcome at discharge, but it could reduce the LOS-NICU (p
I have anecdotal experience with pioglitazone in this setting, especially if the patient will be taking concomitant corticosteroids for a sustained period of time. Pioglitazone offers modest reduction of SBP, reduces insulin resistance, and aids in control of blood glucose secondary to corticosteroids. In an adult, start with 15 mg once daily, titrate up to glucose response and/or hypoglycemia.